MIN JUNG KANG: Open Payments
NPI 1063889632 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,576 in 23 payments from 9 companies in 2025. Trend: 2023 $1,069 · 2024 $811 · 2025 $1,576
Food & beverage: $1,576
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $307 |
| Alkermes, Inc. | 2 | $232 |
| Axsome Therapeutics, Inc. | 2 | $195 |
| Inspire Medical Systems, Inc. | 7 | $189 |
| JAZZ PHARMACEUTICALS INC. | 5 | $181 |
| Neurocrine BioSciences, Inc. | 1 | $133 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| ABBVIE INC. | 1 | $123 |
| Supernus Pharmaceuticals, Inc. | 1 | $92 |
Products named: FANAPT, Auvelity, INSPIRE, XYWAV, INGREZZA, SPRAVATO, LYBALVI, VRAYLAR.
Industry payments across MS — which companies pay providers there.
